EMD Serono Submits Comments on FDA's AI Guidance for Drug Development
2025-05-04
PubComNonGov2025-05-04
By Jaymar B. Talang
WASHINGTON, May 4 -- EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, has submitted comments to the Food and Drug Administration (FDA) regarding its draft guidance on the use of . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, May 4 -- EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, has submitted comments to the Food and Drug Administration (FDA) regarding its draft guidance on the use of . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2025